دورية أكاديمية
Scabies vaccines: where we stand and challenges ahead.
| العنوان: | Scabies vaccines: where we stand and challenges ahead. |
|---|---|
| المؤلفون: | Sharaf MS; Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. mahmoud.sharaf@med.tanta.edu.eg. |
| المصدر: | Parasitology research [Parasitol Res] 2024 Jul 24; Vol. 123 (7), pp. 285. Date of Electronic Publication: 2024 Jul 24. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer International Country of Publication: Germany NLM ID: 8703571 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1955 (Electronic) Linking ISSN: 09320113 NLM ISO Abbreviation: Parasitol Res Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Berlin : Springer International, c1987- |
| مواضيع طبية MeSH: | Scabies*/prevention & control , Vaccines*/immunology , Sarcoptes scabiei*/immunology , Sarcoptes scabiei*/drug effects, Animals ; Humans |
| مستخلص: | Scabies is an itchy skin disease caused by the burrowing mite, Sarcoptes scabiei. During their lifespan, female mites invade the stratum corneum and create tunnels in which they reside, move, feed, deposit fecal pellets, and lay eggs. Globally, more than 200 million people are estimated to be affected by scabies annually. Currently, using scabicidal agents is the only approved method for treating scabies. However, resistance to commonly used agents such as permethrin and ivermectin has been observed in scabies mites. Therefore, the development of vaccines for scabies, either as a preventative measure or for treatment, is crucial to control such neglected diseases. Since the host could evolve a protective immune response that could prevent re-infestation by scabies mites, vaccine development is theoretically possible. This review aims to provide a comprehensive overview of the ongoing challenges regarding the currently available control measures for scabies. It also explores the promising path of scabies vaccine development, highlighting the current state of research and challenges that need to be addressed to develop new and innovative measures for both treating and preventing scabies infections. (© 2024. The Author(s).) |
| References: | PLoS Negl Trop Dis. 2016 Oct 12;10(10):e0005030. (PMID: 27732588) J Med Entomol. 2006 Mar;43(2):283-7. (PMID: 16619612) J Theor Biol. 2014 May 21;349:121-34. (PMID: 24512916) J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248-1253. (PMID: 28639722) Clin Exp Dermatol. 2017 Jul;42(5):481-487. (PMID: 28556185) Int J Immunopathol Pharmacol. 2016 Jun;29(2):188-94. (PMID: 26813861) Cureus. 2017 Mar 19;9(3):e1102. (PMID: 28435762) Arch Dermatol. 2011 Apr;147(4):468-73. (PMID: 21482897) Br J Dermatol. 2020 Feb;182(2):511-513. (PMID: 31508811) Vet Parasitol. 2005 Oct 10;133(1):101-9. (PMID: 16118041) PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2928. (PMID: 24945501) Parasit Vectors. 2016 Aug 08;9(1):435. (PMID: 27502394) PLoS Negl Trop Dis. 2015 Oct 22;9(10):e0004188. (PMID: 26492406) Exp Ther Med. 2014 Jan;7(1):204-208. (PMID: 24348791) PLoS One. 2012;7(7):e40489. (PMID: 22792350) Parasite. 2016;23:54. (PMID: 27905271) Infect Genet Evol. 2017 Jul;51:227-234. (PMID: 28411163) Int J Dermatol. 2011 Dec;50(12):1501-5. (PMID: 22097996) Exp Parasitol. 2020 Oct;217:107961. (PMID: 32777223) J Med Entomol. 2010 Sep;47(5):877-83. (PMID: 20939384) Br J Dermatol. 2018 Oct;179(4):889-895. (PMID: 29624634) PLoS Negl Trop Dis. 2019 Mar 8;13(3):e0007182. (PMID: 30849124) J Cutan Pathol. 2013 Jan;40(1):6-10. (PMID: 23110486) PLoS Negl Trop Dis. 2018 May 24;12(5):e0006549. (PMID: 29795566) Parasit Vectors. 2023 Nov 14;16(1):413. (PMID: 37964301) Lancet Glob Health. 2020 Jan;8(1):e92-e100. (PMID: 31839144) J Allergy Clin Immunol. 2015 Feb;135(2):539-48. (PMID: 25445830) Clin Vaccine Immunol. 2010 Sep;17(9):1428-38. (PMID: 20631334) PLoS Negl Trop Dis. 2015 Mar 02;9(3):e0003498. (PMID: 25730203) Parasite Immunol. 2014 Nov;36(11):594-604. (PMID: 25040151) Exp Parasitol. 2023 Feb;245:108442. (PMID: 36509170) Parasitol Res. 2023 Nov;122(11):2477-2490. (PMID: 37656230) PLoS One. 2013 Aug 05;8(8):e71143. (PMID: 23940705) Exp Appl Acarol. 2014 Jul;63(3):401-12. (PMID: 24729069) Rev Esp Sanid Penit. 2021 Jan-Apr;23(1):37-42. (PMID: 33847704) Clin Exp Allergy. 2009 Jul;39(7):943-55. (PMID: 19400900) PLoS Pathog. 2013 Mar;9(3):e1003243. (PMID: 23555256) PeerJ. 2018 Jul 27;6:e5291. (PMID: 30065882) Vaccines (Basel). 2020 Mar 16;8(1):. (PMID: 32187979) Parasit Vectors. 2018 Nov 20;11(1):599. (PMID: 30454025) J Am Acad Dermatol. 2007 Jan;56(1):53-62. (PMID: 17190621) Infect Dis Rep. 2022 Jun 16;14(3):479-491. (PMID: 35735761) |
| فهرسة مساهمة: | Keywords: Sarcoptes scabiei; Immunity; Scabies; Treatment; Vaccines |
| المشرفين على المادة: | 0 (Vaccines) |
| تواريخ الأحداث: | Date Created: 20240724 Date Completed: 20240724 Latest Revision: 20240727 |
| رمز التحديث: | 20240727 |
| مُعرف محوري في PubMed: | PMC11269436 |
| DOI: | 10.1007/s00436-024-08298-8 |
| PMID: | 39046602 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-1955 |
|---|---|
| DOI: | 10.1007/s00436-024-08298-8 |